<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nagaoka K</submitter><funding>JSPS KAKENHI</funding><funding>Japan Agency for Medical Research and Development (AMED)</funding><pagination>1789</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12650950</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(22)</volume><pubmed_abstract>Targeting mutation-derived neoantigens is a promising strategy for personalized immunotherapies. However, identifying true neoantigens and cognate T cell receptors (TCRs) remains challenging because computational prediction of neoantigen peptides is uncertain and most tumor-infiltrating lymphocytes are bystanders rather than tumor-reactive, necessitating functional validation. Here, we developed NeoPAIR-T (Neoantigen-TCR Pairing Assay using reporter T cells), a functional assay based on co-culture of TCR-T reporter cells and autologous antigen-presenting cells (APCs) to screen neoantigen-TCR pairs. Reporter T cells are Jurkat-derived cells engineered to express a luciferase/eGFP dual reporter, providing quantitative readouts of TCR activation, while APCs are immortalized autologous cells t</pubmed_abstract><journal>Cells</journal><pubmed_title>NeoPAIR-T: Functional Mapping of Neoantigen-TCR Pairs Using a CRISPR-Engineered Jurkat Reporter System.</pubmed_title><pmcid>PMC12650950</pmcid><funding_grant_id>24ama221321h0002</funding_grant_id><funding_grant_id>23H02762</funding_grant_id><pubmed_authors>Nagaoka K</pubmed_authors><pubmed_authors>Kobayashi Y</pubmed_authors><pubmed_authors>Kakimi K</pubmed_authors></additional><is_claimable>false</is_claimable><name>NeoPAIR-T: Functional Mapping of Neoantigen-TCR Pairs Using a CRISPR-Engineered Jurkat Reporter System.</name><description>Targeting mutation-derived neoantigens is a promising strategy for personalized immunotherapies. However, identifying true neoantigens and cognate T cell receptors (TCRs) remains challenging because computational prediction of neoantigen peptides is uncertain and most tumor-infiltrating lymphocytes are bystanders rather than tumor-reactive, necessitating functional validation. Here, we developed NeoPAIR-T (Neoantigen-TCR Pairing Assay using reporter T cells), a functional assay based on co-culture of TCR-T reporter cells and autologous antigen-presenting cells (APCs) to screen neoantigen-TCR pairs. Reporter T cells are Jurkat-derived cells engineered to express a luciferase/eGFP dual reporter, providing quantitative readouts of TCR activation, while APCs are immortalized autologous cells t</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-05-20T03:20:19.081Z</modification><creation>2026-05-20T03:13:48.265Z</creation></dates><accession>S-EPMC12650950</accession><cross_references><pubmed>41294842</pubmed><doi>10.3390/cells14221789</doi></cross_references></HashMap>